Back
Humacyte 10K Form
Sell
34
HUMA
Humacyte
Last Price:
4.11
Seasonality Move:
-6.86%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive HUMA News And Ratings
See the #1 stock for the next 7 days that we like better than HUMA
HUMA Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-23.84M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.53 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -1.34000 |
|---|---|
| Net Income (TTM): | $-152.87M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Humacyte Earnings Forecast
Key Humacyte Financial Ratios
- The Interest Expense is -5.96% of Operating Income.
- Per Share Earnings over the last 4 years have been positive in 2 years.
Humacyte Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | HUMA |
| Website: | humacyte.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |